CRE in Companion Animals

Get Started. It's Free
or sign up with your email address
CRE in Companion Animals by Mind Map: CRE in Companion Animals

1. IncK2

2. Location

2.1. North America

2.2. South America

2.3. Europe

2.4. Asia

2.5. Africa

2.6. Australia

3. Negative Studies

4. Survey of Carbapenemase-Producing Enterobacteriaceae in Companion Dogs in Madrid, Spain (González-Torralba et al., 2016)

5. Enterobacter cloacae Complex Sequence Type 171 Isolates Expressing KPC-4 Carbapenemase Recovered from Canine Patients in Ohio. (Daniels et al., 2018)

6. Plasmids

6.1. IncX3

6.2. IncFIB

6.3. IncHI2

6.4. IncI1-type

6.5. IncFII-type

6.6. IncL

6.7. IncF

6.8. IncL/M-1 type

6.9. IncA/C

6.10. IncI

6.11. IncN

7. Human Involvement

8. Detection of IncN-pST15 One-Health plasmid harboring blaKPC-2 in a hypermucoviscous Klebsiella pneumoniae CG258 isolated from an infected dog, Brazil (Sellera et al., 2021)

9. Emergence of OXA-48 carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in dogs. (Stolle et al., 2013)

10. Molecular Characteristics of NDM-5-Producing Escherichia coli from a Cat and a Dog in South Korea. (Hong et al., 2020)

11. Pathogenic Escherichia coli in Dogs Reveals the Predominance of ST372 and the Human-Associated ST73 Extra-Intestinal Lineages (Valat et al., 2020)

12. Clonal dissemination of OXA-48-producing Enterobacter cloacae isolates from companion animals in Algeria. (Yousfi et al., 2018)

13. Occurrence and characterization of Escherichia coli ST410 co-harbouring blaNDM-5, blaCMY-42 and blaTEM-190 in a dog from the UK (Reynolds et al., 2019)

14. Complete Genome Sequence of a Carbapenem-Resistant Escherichia coli Isolate with blaNDM-5 from a Dog in the United States (Tyson et al., 2019)

15. Distribution and antimicrobial resistance profiles of bacterial species in stray cats, hospital-admitted cats, and veterinary staff in South Korea. (Jung et al., 2020)

16. Additional Resistance

16.1. Colistin

16.2. Sulfonamide

16.3. Fosfomycin

16.4. Aminoglycoside

16.5. Tetracycline

16.6. Quinolone

16.7. Beta-Lactam

16.8. Trimethoprim

16.9. Chloramphenicol

16.10. Macrolide

17. Emergence of a New Delhi metallo-β-lactamase (NDM-1)-encoding gene in clinical Escherichia coli isolates recovered from companion animals in the United States (Shaheen et al., 2013)

18. Antimicrobial susceptibility of bacterial isolates from urinary tract infections in companion animals in Spain. (Darwich et al., 2021)

19. Risk Factors for the Acquisition of a blaNDM-5 Carbapenem-Resistant Escherichia coli in a Veterinary Hospital. (Lavigne et al., 2021)

20. Species Tested

20.1. Dogs

20.1.1. Found Positive

20.1.2. All Negative

20.2. Cats

20.2.1. Found Positive

20.2.2. All Negative

20.3. Other Companion Animals

20.3.1. Found Positive

20.3.2. All Negative

21. Carbapenemase Gene

21.1. NDM

21.2. OXA-48

21.3. VIM

21.4. KPC

21.5. OXA-181

22. Household transmission of carbapenemase-producing Enterobacteriaceae: a prospective cohort study (Marimuthu et al., 2021)

23. Study Design

23.1. Active surveillance

23.2. Passive surveillance

23.3. Case Report/Case Series

24. Inter-host Transmission of Carbapenemase-Producing Escherichia coli among Humans and Backyard Animals. (Li et al., 2019)

25. First Detection of New Delhi Metallo-beta-Lactamase-5-Producing Escherichia coli from Companion Animals in Korea. (Hong et al., 2019)

26. Prevalence of antimicrobial resistance and resistance genes in faecal Escherichia coli isolates recovered from healthy pets (Costa et al., 2008)

27. Beta-Lactamases in Ampicillin-Resistant Escherichia coli Isolates from Foods, Humans, and Healthy Animals (Briñas et al., 2002)

28. Poor infection prevention and control standards are associated with environmental contamination with carbapenemase-producing Enterobacterales and other multidrug-resistant bacteria in Swiss companion animal clinics. (Schmidt et al., 2020)

29. Genomic features of a polymyxin-resistant Klebsiella pneumoniae ST491 isolate co-harbouring blaCTX-M-8 and qnrE1 genes from a hospitalised cat in Sao Paulo, Brazil. (Sartori et al., 2020)

30. Antimicrobial‐resistant Enterobacteriaceae recovered from companion animal and livestock environments (Adams et al., 2018)

31. IncH-type plasmid harboring bla CTX-M-15, bla DHA-1, and qnrB4 genes recovered from animal isolates. (Schluter et al, 2014)

32. Multiresistant extended-spectrum β-lactamase-producing Enterobacteriaceae from humans, companion animals and horses in central Hesse, Germany. (Schmiedel et al., 2014)

33. Characterization of ESBL-and AmpC-producing Enterobacteriaceae from diseased companion animals in Europe (Bogaerts et al., 2015

34. Emergence of Carbapenemase-Producing Escherichia coli Isolated from Companion Animals in Algeria (Yousfi et al., 2016)

35. Extended spectrum β-lactamase and plasmid mediated quinolone resistance in Escherichia coli fecal isolates from healthy companion animals in Algeria.(Yousfi et al., 2016)

36. Host-Specific Patterns of Genetic Diversity among IncI1-Igamma and IncK Plasmids Encoding CMY-2 beta-Lactamase in Escherichia coli Isolates from Humans, Poultry Meat, Poultry, and Dogs in Denmark (Hansen et al., 2016)

37. Antimicrobial resistance profiles and genotypes of extended-spectrum β-lactamase-and AmpC β-lactamase-producing Klebsiella pneumoniae isolated from dogs in Beijing, China. (Liu et al., 2017)

38. In vitro efficacy of 16 antimicrobial drugs against a large collection of β-lactamase-producing isolates of extraintestinal pathogenic Escherichia coli from dogs and cats. (Shimizu et al., 2017)

39. Antimicrobial resistance in clinical Escherichia coli isolated from companion animals in Australia. (Saputra et al., 2017)

40. Occurrence of OXA-48 Carbapenemase and Other β-Lactamase Genes in ESBL-Producing Multidrug Resistant Escherichia coli from Dogs and Cats in the United States, 2009–2013. (Liu et al., 2016)

41. New Delhi Metallo-β-Lactamase-5–Producing Escherichia coli in Companion Animals, United States (Cole et al., 2020)

41.1. Sharing more than friendship - transmission of NDM-5 ST167 and CTX-M-9 ST69 Escherichia coli between dogs and humans in a family, Finland, 2015. (Grönthal et al., 2018)

42. OXA-48-producing ST372 Escherichia coli in a French dog. (Melo et al., 2016)

43. Isolation and plasmid characterization of carbapenemase (IMP-4) producing Salmonella enterica Typhimurium from cats (Abraham et al., 2016)

44. Companion Animals Emerged as an Important Reservoir of Carbapenem-Resistant Enterobacteriaceae: A Report from India (Bandyopadhyay, 2021)

45. Multispecies and Clonal Dissemination of OXA-48 Carbapenemase in Enterobacteriaceae From Companion Animals in Germany, 2009-2016 (Pulss et al., 2018)

46. Emergence of blaNDM-5 in Enterobacteriaceae Isolates from Companion Animals in Guangzhou, China. (Wang et al., 2020)

47. Carbapenemase IncF-borne blaNDM-5 gene in the E. coli ST167 high-risk clone from canine clinical infection, Italy. (Alba et al., 2021)

48. Circulation of emerging NDM‐5‐producing Escherichia coli among humans and dogs in Egypt. (Ramadan et al., 2020)

49. OXA-181-Producing Extraintestinal Pathogenic Escherichia coli Sequence Type 410 Isolated from a Dog in Portugal. (Brilhante et al., 2020)

50. The Public Health Burden of Virulent Extended-Spectrum beta-Lactamase-Producing Klebsiella pneumoniae Strains Isolated from Diseased Horses. (Samir et al., 2022)

51. Characterization of 2 Klebsiella pneumoniae carbapenemase–producing Enterobacterales isolated from canine rectal swabs. (Cole et al., 2021)

52. Comparative genomic analysis of plasmids encoding metallo-β-lactamase NDM-5 in Enterobacterales Korean isolates from companion dogs (Kyung et al., 2022)

53. Assess acquisition, prevalence of and risk factors for MDRO carriage in dogs and cats presented to veterinary clinics or practices in Switzerland. (Dazio et al., 2021)

54. Colonization dynamics of Klebsiella pneumoniae in the pet animals and human owners in a single household. (Chen et al., 2021)

55. The occurrence of Salmonella, extended-spectrum β-lactamase producing Escherichia coli and carbapenem resistant non-fermenting Gram-negative bacteria in a backyard poultry flock environment (Shah et al., 2020)

56. Risk factors associated with faecal carriage of extended-spectrum cephalosporin-resistant Escherichia coli among dogs in Southeast Brazil. (Salgado-Caxito et al., 2021)

57. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae Isolated from healthy and sick dogs in Portugal. (Carvalho et al., 2020)

58. Two high-risk clones of carbapenemase-producing Klebsiella pneumoniae that cause infections in pets and are present in the environment of a veterinary referral hospital. (Brilhante et al, 2021)

59. Employees of Swiss veterinary clinics colonized with epidemic clones of carbapenemase-producing Escherichia coli. (Endimiani et al., 2020)

60. Shedding of OXA-181 carbapenemase-producing Escherichia coli from companion animals after hospitalisation in Switzerland: an outbreak in 2018 (Nigg et al., 2019)

61. Multidrug-resistant Escherichia coli isolated from canine faeces in a public park in Quito, Ecuador (Ortega-Paredes et al., 2019)

62. First report of a blaNDM-5-harbouring Escherichia coli ST167 isolated from a wound infection in a dog in Switzerland. (Peterhans et al., 2018)

63. β-lactam and fluoroquinolone-resistant enterobacteriaceae recovered from the environment of human and veterinary tertiary care hospitals. (Mathys et al., 2018)

64. Environmental testing

65. blaNDM-1-producing multidrug-resistant Escherichia coli isolated from a companion dog in China (Cui et al., 2018)